the California Department of Public Health (CDPH) added a new measure to
the Quality and Accountability Supplemental Payment Program (QASP) for the
18-19 performance period. Beginning July 1, 2018, the Antipsychotic Medication
Usage Long Stay measure will be included in the calculation of the QASP awards.
Antipsychotic Medication Usage Long Stay measure for QASP differs from the
5-Star Quality Measure. For QASP, the measure excludes the use of antipsychotic
medication in the cases of traumatic brain injury, manic depression and
psychotic disorder. The details of this new measure can be found here.
In addition to
adding a measure, CDPH has retired the Physical Restraints Long Stay measure
from the calculation of the QASP awards beginning July 1, 2018.
We hope you
find this information useful. Mueller Prost offers a calculator to
track your possible QASP award and make sure you're on target to receive the
largest possible award. Please contact us if you're interested in maximizing
your QASP awards dollars.